RNU7-126P

Across TCGA pan-cancer cohorts, RNU7-126P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-126P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU7-126P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-126P expression acts as an unfavorable survival marker.

BRCA, DLBC, and LIHC are the cancer types where RNU7-126P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.572	0.963	.007	48	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
LIHC	OS	Tertile	All	0.144	0.688	.013	27	view →
LGG	DFS	Tertile	All	0.268	0.753	.029	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-126P–BRCA (OS)

Open the BRCA breakdown →